Back to Search
FRIEDA RIVERA, M.D.
M.D.
Pediatrics Physician
NPI: 1710077433Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
J6219(TX)
Research & Publications (20)
Calpain inhibitors prevent p38 MAPK activation and germ cell apoptosis after heat stress in pubertal rat testes.
PMID 19598167·J Cell Physiol·2009
7-preclinical
Consensus on the treatment of pancreatic cancer in Spain.
PMID 19451062·Clin Transl Oncol·2009
6-review
Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.
PMID 19370171·Mar Drugs·2009
3-trial
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.
PMID 19567451·Ann Oncol·2009
3-trial
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
PMID 19406901·Ann Oncol·2009
3-trial
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
PMID 19465426·Ann Oncol·2009
4-observational
Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma.
PMID 19540072·Int J Radiat Oncol Biol Phys·2009
3-trial
Cross-national associations between parent and peer communication and psychological complaints.
PMID 19639255·Int J Public Health·2009
8-other
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.
PMID 19111473·Crit Rev Oncol Hematol·2009
3-trial
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.
PMID 19451431·J Clin Oncol·2009
3-trial
Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy.
PMID 19131170·Cancer Treat Rev·2009
6-review
A nuclear magnetic resonance biomarker for neural progenitor cells: is it all neurogenesis?
PMID 18988707·Stem Cells·2009
7-preclinical
[Enema in a patient with renal failure: a cause of severe hyperphosphatemia].
PMID 19016646·Nefrologia·2008
5-case
Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
PMID 19017933·J Immunol·2008
7-preclinical
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
PMID 17901953·Cancer Chemother Pharmacol·2008
3-trial
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.
PMID 18421054·J Clin Oncol·2008
3-trial
Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
PMID 17964791·Bioorg Med Chem·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4410 NAVIGATION BLVD, SUITE 278
HOUSTON, TX 77011 - Phone
- (713) 547-8282
Quick Facts
- NPI
- 1710077433
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile